151 lines
68 KiB
Text
151 lines
68 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK547841">
|
|
<meta name="ncbi_domain" content="livertox">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK547841/?report=reader">
|
|
<meta name="ncbi_pagename" content="Move Free - LiverTox - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Move Free - LiverTox - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/livertox/Morphine/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/livertox/MoxetumomabPasudotox/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/livertox/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]">
|
|
<meta name="citation_title" content="Move Free">
|
|
<meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases">
|
|
<meta name="citation_date" content="2020/02/26">
|
|
<meta name="citation_pmid" content="31643180">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK547841/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Move Free">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases">
|
|
<meta name="DC.Date" content="2020/02/26">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK547841/">
|
|
<meta name="description" content="Move Free is a proprietary line of multi-ingredient dietary supplements (MIDS) marketed as aids for joint health and “to help ease joint discomfort, maintain strength and flexibility and help support and nourish cartilage”. The major ingredients in the products include glucosamine, chondroitin, hyaluronic acid and methylsufonylmethane (MSM). There have been several reports of clinically apparent liver injury in patients taking Move Free products; however, the specific ingredient(s) in the various products that might cause liver injury has not been identified and these ingredients may no longer be included in currently available products.">
|
|
<meta name="og:title" content="Move Free">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="Move Free is a proprietary line of multi-ingredient dietary supplements (MIDS) marketed as aids for joint health and “to help ease joint discomfort, maintain strength and flexibility and help support and nourish cartilage”. The major ingredients in the products include glucosamine, chondroitin, hyaluronic acid and methylsufonylmethane (MSM). There have been several reports of clinically apparent liver injury in patients taking Move Free products; however, the specific ingredient(s) in the various products that might cause liver injury has not been identified and these ingredients may no longer be included in currently available products.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK547841/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/livertox/MoveFree/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK547841/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8ED5CF7D7E2291000000000085006E.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK547841/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/livertox/Morphine/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">Move Free</div><div class="j">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</div></div><div class="tail"><a href="/books/n/livertox/MoxetumomabPasudotox/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK547841/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK547841/&text=Move%20Free"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/livertox/?report=reader">Title Information</a><a href="/books/n/livertox/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK547841/?report=classic">Switch to classic view</a><a href="/books/NBK547841/pdf/Bookshelf_NBK547841.pdf">PDF (131K)</a><a href="/books/NBK547841/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK547841%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8ED5CF7D7E2291000000000085006E.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK547841_"><span class="title" itemprop="name">Move Free</span></h1><p class="fm-aai"><a href="#_NBK547841_pubdet_">Publication Details</a></p></div></div><div class="body-content whole_rhythm" itemprop="text"><div id="MoveFree.OVERVIEW"><h2 id="_MoveFree_OVERVIEW_">OVERVIEW</h2><div id="MoveFree.Introduction"><h3>Introduction</h3><p>Move Free is a proprietary line of multi-ingredient dietary supplements (MIDS) marketed as aids for joint health and “to help ease joint discomfort, maintain strength and flexibility and help support and nourish cartilage”. The major ingredients in the products include glucosamine, chondroitin, hyaluronic acid and methylsufonylmethane (MSM). There have been several reports of clinically apparent liver injury in patients taking Move Free products; however, the specific ingredient(s) in the various products that might cause liver injury has not been identified and these ingredients may no longer be included in currently available products.</p></div><div id="MoveFree.Background"><h3>Background</h3><p>Move Free is a proprietary product name for an array of multi-ingredient herbal and dietary supplements (MIDS) meant to ease joint discomfort. The Move Free brand is currently produced by Reckitt Benckiser Group plc (Slough, England) which purchased its previous distributor, Schiff Nutrition International (Salt Lake City, UT), in 2012. The constituents of the various Move Free products vary, but are largely glucosamine, chondroitin and hyaluronic acid with various combinations of vitamins (vitamin D3), minerals (boron) and selected nutritional supplements such as krill oil and astaxanthin (a keto-carotenoid anti-oxidant). The ingredients and their concentrations in some of the products have been modified over time. Previous Move Free products have included mixtures of herbal agents including Chinese skullcap (Scutellaria baicalensis) and black catechu (Acacia catechu). Presently, however, Move Free products do not list any herbal constituents although several mention “Uniflex (FruiteX-B Calcium Fructoborate)”.</p><p>The common Move Free products that are currently marketed are given in the Table below with a listing of their ingredients as provided in the product labels. Because the products are considered dietary supplements, they are not subject to the usual efficacy and safety evaluation given to medications. However, all nutritional supplements are subject to rules regarding purity and good manufacturing practices. Dietary supplements are not recommended for specific medical conditions, but can be advertised as being supportive of general health or a specific tissue or organ health. These multi-ingredient products appear to be generally safe and well tolerated, but prospective studies of their efficacy, tolerance and safety have not been published.</p><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figMoveFreeTselectedmovefreeproductsf"><a href="/books/NBK547841/table/MoveFree.T.selected_move_free_products_f/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figMoveFreeTselectedmovefreeproductsf" rid-ob="figobMoveFreeTselectedmovefreeproductsf"><img class="small-thumb" src="/books/NBK547841/table/MoveFree.T.selected_move_free_products_f/?report=thumb" src-large="/books/NBK547841/table/MoveFree.T.selected_move_free_products_f/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="MoveFree.T.selected_move_free_products_f"><a href="/books/NBK547841/table/MoveFree.T.selected_move_free_products_f/?report=objectonly" target="object" rid-ob="figobMoveFreeTselectedmovefreeproductsf">Table</a></h4><p class="float-caption no_bottom_margin">Selected Move Free Products (February 2016) </p></div></div></div><div id="MoveFree.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>The initial reports of liver injury attributed to Move Free were published in 2010, with subsequent reports in 2012 and 2013, all from the United States. These publications described an acute hepatocellular injury arising within 1 to 3 weeks of starting a Move Free product that contained glucosamine, chondroitin and a proprietary herbal mixture of Chinese skullcap (Scutellaria baicalensis) and black catechu (Acacia catechu). The injury was moderate in severity and resolved within 1 to 2 months of stopping the supplement. Immunoallergic and autoimmune features were not present, and the injury resolved without residual in all cases. One patient restarted the product after at least partial recovery and redeveloped a similar pattern of liver injury. While further cases have not been described, prospective studies of drug induced liver injury from the United States mentioned 3 cases of acute liver injury linked to Move Free products, all from 2012-2013. At present, Move Free products do not list a proprietary herbal component but do mention a proprietary mineral complex with a similar name: “Uniflex”.</p><p>Likelihood score: C (probable rare cause of clinically apparent liver injury).</p></div><div id="MoveFree.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The liver injury attributed to Move Free products has been reported to be due to Chinese skullcap, but the mechanism by which this herb might cause liver injury is unexplained. Indeed, Chinese skullcap has hepatoprotective activity in animal models of liver disease. Contamination or misidentification of the herbal components is always a possibility in explaining the appearance of liver injury.</p></div><div id="MoveFree.Outcome_and_Management"><h3>Outcome and Management</h3><p>The liver injury that has been attributed to Move Free products has usually been mild-to-moderate in severity and self-limited in course, resolving in 1 to 2 months of stopping the preparations. Move Free has not been linked to instances of acute liver failure, chronic hepatitis or vanishing bile duct syndrome. In patients presenting with acute, unexplained liver injury, all HDS products should be discontinued and the case reported to federal registries. It is also helpful to carefully define what products were being taken and at what doses and for how long. Retrieval of the actual product or products can also be helpful as progress is being made in the identification of ingredients by advanced chemical and biochemical methods.</p><p>Drug Class: <a href="/books/n/livertox/HerbalDietarySuppl/?report=reader">Herbal and Dietary Supplements</a>, Nutritional Supplements, Multi-Ingredient</p></div></div><div id="MoveFree.CASE_REPORT"><h2 id="_MoveFree_CASE_REPORT_">CASE REPORT</h2><div id="MoveFree.Case_1_Repeated_episodes_of_acu"><h3>Case 1. Repeated episodes of acute hepatitis after use of Move Free.(<a class="bibr" href="#MoveFree.REF.1" rid="MoveFree.REF.1">1</a>)</h3><p>A 78 year old woman osteoarthritis developed jaundice within 3 weeks of starting “Move Free Advanced”, a proprietary multi-ingredient nutritional supplement advertised to be helpful for joint discomfort. She had no history of liver disease, but had a previous cholecystectomy. She denied alcohol abuse and risk factors for viral hepatitis. She was taking no other medications except for multivitamins. On presentation, serum bilirubin was 7.2 mg/dL, ALT 1626 U/L, AST 1053 U/L, alkaline phosphatase 354 U/L and GGT 599 U/L. Tests for hepatitis A, B and C were negative. She was hospitalized and the Move Free product was stopped. She began to improve without specific therapy and was discharged after a few days (Table). Because her joint symptoms worsened, she restarted the Move Free product and redeveloped jaundice within two weeks. Her laboratory tests were again abnormal in a pattern similar to the initial episode. A liver biopsy showed acute hepatocellular injury with many eosinophils suggestive of drug induced liver injury. Tests for autoantibodies were negative and a CT scan of the abdomen showed no evidence of biliary obstruction or hepatic masses. At this point, the nutritional supplement was suspected to be the cause and was found to be Move Free Advanced and have glucosamine, chondroitin and two herbal ingredients, Chinese skullcap and black catechu listed together as “Uniflex Proprietary Extract: 200 mg”. She was told to avoid its further use and in follow up her symptoms resolved and liver tests improved.</p><div id="MoveFree.Key_Points"><h4>Key Points</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figMoveFreeTd"><a href="/books/NBK547841/table/MoveFree.Td/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figMoveFreeTd" rid-ob="figobMoveFreeTd"><img class="small-thumb" src="/books/NBK547841/table/MoveFree.Td/?report=thumb" src-large="/books/NBK547841/table/MoveFree.Td/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="MoveFree.Td"><a href="/books/NBK547841/table/MoveFree.Td/?report=objectonly" target="object" rid-ob="figobMoveFreeTd">Table</a></h4></div></div></div><div id="MoveFree.Laboratory_Values"><h4>Laboratory Values</h4><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figMoveFreeTe"><a href="/books/NBK547841/table/MoveFree.Te/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figMoveFreeTe" rid-ob="figobMoveFreeTe"><img class="small-thumb" src="/books/NBK547841/table/MoveFree.Te/?report=thumb" src-large="/books/NBK547841/table/MoveFree.Te/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="MoveFree.Te"><a href="/books/NBK547841/table/MoveFree.Te/?report=objectonly" target="object" rid-ob="figobMoveFreeTe">Table</a></h4></div></div></div><div id="MoveFree.Comment"><h4>Comment</h4><p>An elderly woman with osteoarthritis developed an acute hepatitis a few weeks after starting an herbal and dietary supplement called “Move Free Advanced” that was thought to contain glucosamine and chondroitin only, neither of which are considered hepatotoxic. No other cause for the hepatitis was identified, and her physicians assured her that glucosamine and chondroitin were not the reason for the liver injury. Upon restarting the multi-ingredient nutritional supplement, however, she redeveloped jaundice. On closer inspection, the product label of Move Free Advanced also listed a “proprietary” mixture of herbal agents which included Chinese skullcap (Scutellaria baicalensis) and black catechu (Acacia catechu). Chinese skullcap had been implicated in rare cases of drug induced liver injury, although the association was not completely convincing. The recurrence of injury with a similar latency and pattern of enzyme elevations is very convincing evidence that the nutritional supplement was the likely cause of the episode, but the specific ingredient responsible is somewhat unclear and the injury may have been due to a contaminant or misidentified constituent in the proprietary mixture. Current formulations of Move Free products do not mention Chinese skullcap as an ingredient.</p></div></div></div><div id="MoveFree.PRODUCT_INFORMATION"><h2 id="_MoveFree_PRODUCT_INFORMATION_">PRODUCT INFORMATION</h2><p>
|
|
<b>REPRESENTATIVE TRADE NAMES</b>
|
|
</p><p>Move Free®</p><p>
|
|
<b>DRUG CLASS</b>
|
|
</p><p>Herbal and Dietary Supplements</p><p>
|
|
<a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Move+Free" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">COMPLETE LABELING</a>
|
|
</p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div><div id="MoveFree.CHEMICAL_FORMULAS_AND_STRUCTURE"><h2 id="_MoveFree_CHEMICAL_FORMULAS_AND_STRUCTURE_">CHEMICAL FORMULAS AND STRUCTURES</h2><div class="iconblock whole_rhythm clearfix ten_col table-wrap" id="figMoveFreeTf"><a href="/books/NBK547841/table/MoveFree.Tf/?report=objectonly" target="object" title="Table" class="img_link icnblk_img figpopup" rid-figpopup="figMoveFreeTf" rid-ob="figobMoveFreeTf"><img class="small-thumb" src="/books/NBK547841/table/MoveFree.Tf/?report=thumb" src-large="/books/NBK547841/table/MoveFree.Tf/?report=previmg" alt="Image " /></a><div class="icnblk_cntnt"><h4 id="MoveFree.Tf"><a href="/books/NBK547841/table/MoveFree.Tf/?report=objectonly" target="object" rid-ob="figobMoveFreeTf">Table</a></h4></div></div></div><div id="MoveFree.CITED_REFERENCE"><h2 id="_MoveFree_CITED_REFERENCE_">CITED REFERENCE</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="MoveFree.REF.1">Yang L, Aronsohn A, Hart J, Jensen D. Herbal hepatoxicity from Chinese skullcap: A case report. <span><span class="ref-journal">World J Hepatol. </span>2012;<span class="ref-vol">4</span>:231–3.</span> [<a href="/pmc/articles/PMC3409358/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3409358</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22855699" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22855699</span></a>]</div></dd></dl></dl></div><div id="MoveFree.ANNOTATED_BIBLIOGRAPHY"><h2 id="_MoveFree_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 26 February 2020</p><p>Abbreviations: HDS, herbal and dietary supplements.</p><ul class="first-line-outdent"><li><div class="bk_ref" id="MoveFree.REF.zimmerman.1999">Zimmerman HJ. Unconventional drugs. Miscellaneous drugs and diagnostic chemicals. In, Zimmerman, HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott 1999: pp. 731-4.<div><i>(Expert review of hepatotoxicity published in 1999; Move Free products, glucosamine, chondroitin and hyaluronic acid are not discussed).</i></div></div></li><li><div class="bk_ref" id="MoveFree.REF.seeff.2013">Seeff L, Stickel F, Navarro VJ. Hepatotoxicity of herbals and dietary supplements. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013, pp. 631-58.<div><i>(Review of hepatotoxicity of herbal and dietary supplements [HDS]; does not mention Move Free products, glucosamine, chondroitin or hyaluronic acid).</i></div></div></li><li><div class="bk_ref" id="MoveFree.REF.russo.2004.1018">Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug-induced liver injury in the United States. <span><span class="ref-journal">Liver Transpl. </span>2004;<span class="ref-vol">10</span>:1018–23.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15390328" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 15390328</span></a>]<div>
|
|
<i>(Among ~50,000 liver transplants reported to UNOS between 1990 and 2002, 270 [0.5%] were done for drug induced acute liver failure, including 7 [5%] for HDS, but the specific herbs and products implicated were not listed).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.garc_acort_s.2008.688">García-Cortés M, Borraz Y, Lucena MI, Peláez G, Salmerón J, Diago M, Martínez-Sierra MC, et al. Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry. <span><span class="ref-journal">Rev Esp Enferm Dig. </span>2008;<span class="ref-vol">100</span>:688–95.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19159172" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19159172</span></a>]<div>
|
|
<i>(Among 521 cases of drug induced liver injury submitted to Spanish registry, 13 [2%] were due to HDS, but no Move Free product was implicated).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.jacobsson.2009.1039">Jacobsson I, Jönsson AK, Gerdén B, Hägg S. Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden. <span><span class="ref-journal">Pharmacoepidemiol Drug Saf. </span>2009;<span class="ref-vol">18</span>:1039–47.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19650152" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 19650152</span></a>]<div>
|
|
<i>(Review of 778 spontaneous reports of adverse reactions to HDS to a Swedish Registry found 31 with increased liver enzymes, 26 with elevated aminotransferase levels, 22 with mixed liver reaction and 12 with hepatitis; agents implicated in causing liver injury included valerian, ginseng, green tea, and aloe vera; glucosamine, chondroitin, skullcap, black catechu and Move Free products were not specifically mentioned).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.linnebur.2010">Linnebur SA, Rapacchietta OC, Vejar M. Hepatotoxicity associated with Chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature. Pharmacotherapy 2010; 30(7): 750, 258e-262e. [<a href="https://pubmed.ncbi.nlm.nih.gov/20586134" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20586134</span></a>]<div><i>(2 cases: 71 and 85 year old women with osteoarthritis developed fatigue a week after starting a Move Free product [containing Chinese skullcap] and were later found to have abnormal liver tests [peak bilirubin 2.0 and 0.2 mg/dL, ALT 650 and 54 U/L, Alk P 310 and 144 U/L], which resolved with 4-8 weeks of stopping).</i></div></div></li><li><div class="bk_ref" id="MoveFree.REF.reuben.2010.2065">Reuben A, Koch DG, Lee WM., Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. <span><span class="ref-journal">Hepatology. </span>2010;<span class="ref-vol">52</span>:2065–76.</span> [<a href="/pmc/articles/PMC3992250/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992250</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20949552" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20949552</span></a>]<div>
|
|
<i>(Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 [11%] were attributed to drug induced liver injury of which 12 [9%] were due to HDS, including several herbal mixtures, usnic acid, Ma Huang, black cohosh, and Hydroxycut; Move Free products were not mentioned).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.stickel.2011.595">Stickel F, Kessebohm K, Weimann R, Seitz HK. Review of liver injury associated with dietary supplements. <span><span class="ref-journal">Liver Int. </span>2011;<span class="ref-vol">31</span>:595–605.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21457433" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21457433</span></a>]<div>
|
|
<i>(Review of current understanding of liver injury from herbals and dietary supplements focusing upon Herbalife and Hydroxycut products, green tea, usnic acid, noni juice, Chinese herbs, vitamin A and anabolic steroids; no mention of Move Free, glucosamine, chondroitin or Chinese skullcap).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.yang.2012.231">Yang L, Aronsohn A, Hart J, Jensen D. Herbal hepatoxicity from Chinese skullcap: A case report. <span><span class="ref-journal">World J Hepatol. </span>2012;<span class="ref-vol">4</span>:231–3.</span> [<a href="/pmc/articles/PMC3409358/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3409358</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22855699" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22855699</span></a>]<div>
|
|
<i>(78 year old woman with osteoarthritis developed jaundice 3 weeks after starting Move Free Advanced [bilirubin 7.2 mg/dL, ALT 1626 U/L, Alk P 354 U/L] which resolved on stopping, but recurred when she restarted the product [bilirubin 4.7 mg/dL, ALT 1206 U/L, Alk P 286 U/L], the product containing glucosamine and chondroitin but also “Uniflex Proprietary Extract” of Chinese skullcap and black catechu: Case 1).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.dhanasekaran.2013.965092">Dhanasekaran R, Owens V, Sanchez W. Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates. <span><span class="ref-journal">Case Reports Hepatol. </span>2013;<span class="ref-vol">2013</span>:965092. </span> [<a href="/pmc/articles/PMC4238172/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4238172</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25431706" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25431706</span></a>]<div>
|
|
<i>(62 year old woman developed shortness of breath and jaundice two weeks after starting a Move Free product [containing Chinese skullcap] with pulmonary infiltrates and abnormal liver tests [bilirubin 6.9 mg/dL, ALT 1247 U/L, Alk P 297 U/L], both liver and pulmonary abnormalities resolving within 8 weeks of stopping).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.bunchorntavakul.2013.3">Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. <span><span class="ref-journal">Aliment Pharmacol Ther. </span>2013;<span class="ref-vol">37</span>:3–17.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23121117" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23121117</span></a>]<div>
|
|
<i>(Systematic review of literature on HDS associated liver injury mentions that skullcap has been implicated in several cases of liver injury).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.teschke.2013.1093">Teschke R, Schulze J, Schwarzenboeck A, Eickhoff A, Frenzel C. Herbal hepatotoxicity: suspected cases assessed for alternative causes. <span><span class="ref-journal">Eur J Gastroenterol Hepatol. </span>2013;<span class="ref-vol">25</span>:1093–8.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23510966" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23510966</span></a>]<div>
|
|
<i>(Review of the literature of case series of suspected HDS related liver injury found evidence of other explanations for the liver injury in 19 of 23 publications involving 278 of 573 patients [49%], and that these other diagnoses weakened the causality assessment in most instances).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.bj_rnsson.2013.1419">Björnsson ES, Bergmann OM, Björnsson HK, Kvaran RB, Olafsson S. Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland. <span><span class="ref-journal">Gastroenterology. </span>2013;<span class="ref-vol">144</span>:1419–25.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23419359" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23419359</span></a>]<div>
|
|
<i>(In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, including 15 [16%] due to herbal and dietary supplements, but none were attributed to a Move Free product or Chinese skullcap).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.licata.2013.13">Licata A, Macaluso FS, Craxì A. Herbal hepatotoxicity: a hidden epidemic. <span><span class="ref-journal">Intern Emerg Med. </span>2013;<span class="ref-vol">8</span>:13–22.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22477279" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22477279</span></a>]<div>
|
|
<i>(Review and commentary on herbal hepatotoxicity discusses pyrrolizidine alkaloids, green tea, Echinacea, kava, usnic acid, ephedra and products made by Herbalife, Hydroxycut and LipoKinetix; no mention of glucosamine, chondroitin, Chinese skullcap or Move Free products).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.navarro.2013.715">Navarro VJ, Seeff LB. Liver injury induced by herbal complementary and alternative medicine. <span><span class="ref-journal">Clin Liver Dis. </span>2013;<span class="ref-vol">17</span>:715–35.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24099027" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24099027</span></a>]<div>
|
|
<i>(Review of HDS induced liver injury including regulatory problems, difficulties in diagnosis and causality assessment; mentions cases of liver injury attributed to Chinese skullcap, three of which were components of Move Free products).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.navarro.2014.1399">Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. <span><span class="ref-journal">Hepatology. </span>2014;<span class="ref-vol">60</span>:1399–408.</span> [<a href="/pmc/articles/PMC4293199/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4293199</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25043597" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25043597</span></a>]<div>
|
|
<i>(Among 85 cases of HDS associated liver injury [not due to anabolic steroids] enrolled in a US prospective study between 2004 and 2013, two [2.3%] were attributed to Move Free products).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.rossi.2014.1069">Rossi S, Navarro VJ. Herbs and liver injury: a clinical perspective. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2014;<span class="ref-vol">12</span>:1069–76.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23924877" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23924877</span></a>]<div>
|
|
<i>(Review of HDS induced liver injury including regulatory problems, difficulties in diagnosis and causality assessment; mentions several cases that have implicated Move Free products, most likely due to Chinese skullcap, although a single case report has implicated glucosamine).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.navarro.2014.172">Navarro VJ, Lucena MI. Hepatotoxicity induced by herbal and dietary supplements. <span><span class="ref-journal">Semin Liver Dis. </span>2014;<span class="ref-vol">34</span>:172–93.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24879982" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24879982</span></a>]<div>
|
|
<i>(Review of HDS induced liver injury including regulatory problems, difficulties in diagnosis and causality assessment; does not discuss Move Free products).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.seeff.2015.517">Seeff LB, Bonkovsky HL, Navarro VJ, Wang G. Herbal products and the liver: a review of adverse effects and mechanisms. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">148</span>:517–532.e3.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25500423" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25500423</span></a>]<div>
|
|
<i>(Extensive review of possible beneficial as well as harmful effects of herbal products on the liver mentions that multi-ingredient supplements have been implicated in many cases of liver injury including proprietary agents marketed under the names Herbalife, Hydroxycut and OxyELITE Pro; Move Free products are not mentioned).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.stickel.2015.851">Stickel F, Shouval D. Hepatotoxicity of herbal and dietary supplements: an update. <span><span class="ref-journal">Arch Toxicol. </span>2015;<span class="ref-vol">89</span>:851–65.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25680499" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25680499</span></a>]<div>
|
|
<i>(Extensive review of liver injury due to HDS mentions that Herbalife has been implicated in 54 cases of liver injury, 7 with a positive rechallenge, but that the cause of the injury remains unknown and that few cases have been published since 2011; does not mention Move Free products).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.chalasani.2015.1340">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al. United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. <span><span class="ref-journal">Gastroenterology. </span>2015;<span class="ref-vol">148</span>:1340–1352.e7.</span> [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25754159" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div>
|
|
<i>(Among 899 cases of drug induced liver injury enrolled in a prospective database between 2004 and 2012, HDS were implicated in 145 [16%], of which 2 were attributed to Move Free products: see Navarro, Barnhart et al. [2014]).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.garc_acort_s.2016.537">García-Cortés M, Robles-Díaz M, Ortega-Alonso A, Medina-Caliz I, Andrade RJ. Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. <span><span class="ref-journal">Int J Mol Sci. </span>2016;<span class="ref-vol">17</span>:537.</span> [<a href="/pmc/articles/PMC4848993/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4848993</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27070596" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27070596</span></a>]<div>
|
|
<i>(Tabular listing of implicated dietary supplements in published cases of liver injury does not mention glucosamine, chondroitin, Move Free or Chinese skullcap).</i>
|
|
</div></div></li><li><div class="bk_ref" id="MoveFree.REF.brown.2017">Brown AC. Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food Chem Toxicol 2017; 107(Pt A): 472-501. [<a href="https://pubmed.ncbi.nlm.nih.gov/27402097" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27402097</span></a>]<div><i>(Description of an online compendium of cases of liver toxicity attributed to HDS products, mentions 2 cases that were attributed to Move Free which contained glucosamine and Skullcap [Linnebur 2010, Yang 2012]).</i></div></div></li><li><div class="bk_ref" id="MoveFree.REF.medinacaliz.2018.1495">Medina-Caliz I, Garcia-Cortes M, Gonzalez-Jimenez A, Cabello MR, Robles-Diaz M, Sanabria-Cabrera J, Sanjuan-Jimenez R, et al. Spanish DILI Registry. Herbal and dietary supplement-induced liver injuries in the Spanish DILI Registry. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2018;<span class="ref-vol">16</span>:1495–502.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29307848" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29307848</span></a>]<div>
|
|
<i>(Among 856 cases of drug induced liver injury enrolled in a Spanish registry between 1994 and 2016, 32 were due to an HDS including 7 attributed to green tea, 6 to Herbalife products, 2 to valerian, and 2 to cascara Sagrada, but none to a Move Free product).</i>
|
|
</div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK547841_pubdet_">Publication Details</h2><h3>Publication History</h3><p class="small">Last Update: <span itemprop="dateModified">February 26, 2020</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p><a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>, Bethesda (MD)</p><h3>NLM Citation</h3><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Move Free. [Updated 2020 Feb 26].<span class="bk_cite_avail"></span></p></div><div class="small-screen-prev"><a href="/books/n/livertox/Morphine/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/livertox/MoxetumomabPasudotox/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="table-wrap" id="figobMoveFreeTselectedmovefreeproductsf"><div id="MoveFree.T.selected_move_free_products_f" class="table"><div class="caption"><p>Selected Move Free Products (February 2016)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547841/table/MoveFree.T.selected_move_free_products_f/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__MoveFree.T.selected_move_free_products_f_lrgtbl__"><table><thead><tr><th id="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Product Name</th><th id="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Condition</th><th id="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Major Listed Ingredients</th></tr></thead><tbody><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Joint Health, Advanced</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Health</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Glucosamine (1.5 g), Chondroitin (200 mg), Hyaluronic acid (3.3 mg), “Uniflex” FruiteX-B Calcium Fructoborate (216 mg).</td></tr><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Joint Health, Advanced Plus with MSM</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Health</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Glucosamine (1.5 g), Chondroitin (200 mg), Methylsulfonylmethane (MSM: 1.5 g), Hyaluronic acid (3.3 mg), “Uniflex” FruiteX-B Calcium Fructoborate (216 mg).</td></tr><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Joint Health, Advanced Plus MSM & Vitamin D3</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Health</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Glucosamine (1.5 g), Chondroitin (200 mg), Methylsulfonylmethane (MSM: 750 mg), Vitamin D3 (2000 IU), Hyaluronic acid (3.3 mg), Uniflex” FruiteX-B Calcium Fructoborate (216 mg).</td></tr><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Joint Health, Night</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Health</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Glucosamine (1.5 g), Chondroitin (200 mg), Melatonin (6 mg)</td></tr><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Ultra Faster Comfort Joint</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Comfort</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Calcium (35 mg), Calcium fructoborate (216 mg)</td></tr><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Ultra Tumeric & Tamarind</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Comfort</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Proprietary Blend (250 mg): Tamarindus indicus (seed) extract and Curcuma longa (rhizome) extract, microcrystalline cellulose</td></tr><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Ultra, Triple Action</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Health</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Cartilage Blend (40 mg), Hyaluronic acid (3.3 mg), Boron (5 mg)</td></tr><tr><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Ultra, Omega</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Joint Health</td><td headers="hd_h_MoveFree.T.selected_move_free_products_f_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Proprietary Blend (353 mg): Krill oil, Hyaluronic acid, Astaxanthin</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobMoveFreeTd"><div id="MoveFree.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547841/table/MoveFree.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__MoveFree.Td_lrgtbl__"><table><tbody><tr><th id="hd_b_MoveFree.Td_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Medication:</th><td headers="hd_b_MoveFree.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Move Free Advanced</td></tr><tr><th id="hd_b_MoveFree.Td_1_1_2_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Pattern:</th><td headers="hd_b_MoveFree.Td_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Hepatocellular (R=10)</td></tr><tr><th id="hd_b_MoveFree.Td_1_1_3_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Severity:</th><td headers="hd_b_MoveFree.Td_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3+ (jaundice, hospitalization)</td></tr><tr><th id="hd_b_MoveFree.Td_1_1_4_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Latency:</th><td headers="hd_b_MoveFree.Td_1_1_4_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3 weeks initially, 2 weeks on rechallenge</td></tr><tr><th id="hd_b_MoveFree.Td_1_1_5_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Recovery:</th><td headers="hd_b_MoveFree.Td_1_1_5_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Not specified</td></tr><tr><th id="hd_b_MoveFree.Td_1_1_6_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Other medications:</th><td headers="hd_b_MoveFree.Td_1_1_6_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Multivitamins</td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobMoveFreeTe"><div id="MoveFree.Te" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547841/table/MoveFree.Te/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__MoveFree.Te_lrgtbl__"><table><thead><tr><th id="hd_h_MoveFree.Te_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Time After<br />Starting</th><th id="hd_h_MoveFree.Te_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Time After<br />Stopping</th><th id="hd_h_MoveFree.Te_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">ALT<br />(U/L)</th><th id="hd_h_MoveFree.Te_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Alk P<br />(U/L)</th><th id="hd_h_MoveFree.Te_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Bilirubin<br />(mg/dL)</th><th id="hd_h_MoveFree.Te_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_MoveFree.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">3 weeks</td><td headers="hd_h_MoveFree.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0</td><td headers="hd_h_MoveFree.Te_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1626</td><td headers="hd_h_MoveFree.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">354</td><td headers="hd_h_MoveFree.Te_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">7.2</td><td headers="hd_h_MoveFree.Te_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Presentation</td></tr><tr><td headers="hd_h_MoveFree.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">5 weeks</td><td headers="hd_h_MoveFree.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">2 weeks</td><td headers="hd_h_MoveFree.Te_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">678</td><td headers="hd_h_MoveFree.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">279</td><td headers="hd_h_MoveFree.Te_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">2.3</td><td headers="hd_h_MoveFree.Te_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Asymptomatic</td></tr><tr><td headers="hd_h_MoveFree.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_MoveFree.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_MoveFree.Te_1_1_1_3 hd_h_MoveFree.Te_1_1_1_4 hd_h_MoveFree.Te_1_1_1_5" colspan="3" rowspan="1" style="text-align:center;vertical-align:top;">Move Free Advanced restarted</td><td headers="hd_h_MoveFree.Te_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_h_MoveFree.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">2 weeks</td><td headers="hd_h_MoveFree.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">0</td><td headers="hd_h_MoveFree.Te_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">1206</td><td headers="hd_h_MoveFree.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">286</td><td headers="hd_h_MoveFree.Te_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">4.7</td><td headers="hd_h_MoveFree.Te_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Symptomatic</td></tr><tr><td headers="hd_h_MoveFree.Te_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">6 weeks</td><td headers="hd_h_MoveFree.Te_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">4 weeks</td><td headers="hd_h_MoveFree.Te_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">120</td><td headers="hd_h_MoveFree.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">126</td><td headers="hd_h_MoveFree.Te_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">0.9</td><td headers="hd_h_MoveFree.Te_1_1_1_6" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">Asymptomatic</td></tr><tr><td headers="hd_h_MoveFree.Te_1_1_1_1 hd_h_MoveFree.Te_1_1_1_2" colspan="2" scope="row" rowspan="1" style="text-align:center;vertical-align:top;">
|
|
<b>Normal Values</b>
|
|
</td><td headers="hd_h_MoveFree.Te_1_1_1_3" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
|
|
<b><60</b>
|
|
</td><td headers="hd_h_MoveFree.Te_1_1_1_4" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
|
|
<b><132</b>
|
|
</td><td headers="hd_h_MoveFree.Te_1_1_1_5" rowspan="1" colspan="1" style="text-align:center;vertical-align:top;">
|
|
<b><1.2</b>
|
|
</td><td headers="hd_h_MoveFree.Te_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr></tbody></table></div></div></article><article data-type="table-wrap" id="figobMoveFreeTf"><div id="MoveFree.Tf" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK547841/table/MoveFree.Tf/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__MoveFree.Tf_lrgtbl__"><table><tbody><tr><th id="hd_b_MoveFree.Tf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">DRUG</th><th id="hd_b_MoveFree.Tf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CAS REGISTRY NUMBER</th><th id="hd_b_MoveFree.Tf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_b_MoveFree.Tf_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">STRUCTURE</th></tr><tr><td headers="hd_b_MoveFree.Tf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Chondroitin</td><td headers="hd_b_MoveFree.Tf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/substance/135263805" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">9007-27-6</a>
|
|
</td><td headers="hd_b_MoveFree.Tf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">(C14-H21-N-O12)n-</td><td headers="hd_b_MoveFree.Tf_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_b_MoveFree.Tf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Glucosamine</td><td headers="hd_b_MoveFree.Tf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/substance/134981549" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">3416-24-8</a>
|
|
</td><td headers="hd_b_MoveFree.Tf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">C6-H13-N-O5</td><td headers="hd_b_MoveFree.Tf_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr><tr><td headers="hd_b_MoveFree.Tf_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Hyaluronic Acid</td><td headers="hd_b_MoveFree.Tf_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
|
<a href="https://pubchem.ncbi.nlm.nih.gov/substance/134989201" ref="pagearea=body&targetsite=entrez&targetcat=link&targettype=pubchem">9004-61-9</a>
|
|
</td><td headers="hd_b_MoveFree.Tf_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Unspecified</td><td headers="hd_b_MoveFree.Tf_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr></tbody></table></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|